[Risk of hepatitis in fibrin adhesion (author's transl)].
A prospective trial was performed on 146 patients, in whom fibrin tissue adhesive was applied during operations. 130 patients, who had received no fibrin glue, served as a control group, and were submitted to the same examinations as the first group of probands. In both groups we could not see any infections with hepatitis B.
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D004338:Drug Combinations / Q000009:adverse effects; D005176:Factor XIII / Q000009:adverse effects*; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000009:adverse effects*; D006509:Hepatitis B / Q000209:etiology*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D010038:Otorhinolaryngologic Diseases / Q000601:surgery; D011446:Prospective Studies; D012306:Risk; D013917:Thrombin / Q000009:adverse effects*; D014014:Tissue Adhesives / Q000009:adverse effects*
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D014014:Tissue Adhesives; D005340:Fibrinogen; D005176:Factor XIII; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D013917:Thrombin
Hepatitisrisiko bei der Fibrinklebung in der HNO-Chirurgie.